Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer
Simona Nanni, … , Alfredo Pontecorvi, Antonella Farsetti
Simona Nanni, … , Alfredo Pontecorvi, Antonella Farsetti
Published July 15, 2002
Citation Information: J Clin Invest. 2002;110(2):219-227. https://doi.org/10.1172/JCI15552.
View: Text | PDF
Article Genetics

Signaling through estrogen receptors modulates telomerase activity in human prostate cancer

  • Text
  • PDF
Abstract

Research Article

Authors

Simona Nanni, Michela Narducci, Linda Della Pietra, Fabiola Moretti, Annalisa Grasselli, Piero De Carli, Ada Sacchi, Alfredo Pontecorvi, Antonella Farsetti

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Effect of the selective aromatase inhibitor letrozole on the interaction...
Effect of the selective aromatase inhibitor letrozole on the interaction between ERs and the hTERT-ERE and on telomerase activity. (a) LNCaP cells were cultured for 16 hours in the absence (lanes 2 and 3) or the presence of E2 (10–7 M, lanes 4 and 5) or T (10–7 M) (lanes 6–9) with (lanes 3, 5, and 9) or without the nonsteroidal aromatase inhibitor letrozole (1 μM) added 1 hour before hormone addition. Nuclear extracts (5 μg) were then prepared and incubated with a 32P-labeled oligonucleotide encompassing the proximal hTERT-ERE. Reaction in the presence of anti-AR (αAR) or anti–ER-β (αERβ) Ab’s are shown in lanes 7 and 8, respectively. Lane 1 corresponds to probe incubated without nuclear extracts. Migration of a slower migrating complex is indicated (arrow). (b) Extracts (0.1 μg) from LNCaP cells treated for 4 hours with R1881 (10–8 M) or T (10–7 M) with or without the nonsteroidal aromatase inhibitor letrozole (1 μM) added 1 hour before ligand addition were assayed for telomerase activity by TRAP.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts